Skip to main content
. 2014 May;99(5):821–829. doi: 10.3324/haematol.2013.096420

Figure 3.

Figure 3.

Changes of prognostic risk categories using IPSS-R compared to IPSS in 40 inv(3)/t(3;3) MDS patients. Int: intermediate; IPSS-R: the Revised International Prognostic Scoring System; IPSS: the International Prognostic Scoring System; MDS: myelodysplastic syndrome.